Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022066170> ?p ?o ?g. }
- W2022066170 endingPage "e1004084" @default.
- W2022066170 startingPage "e1004084" @default.
- W2022066170 abstract "JC polyomavirus (JCV) carriers with a compromised immune system, such as in HIV, or subjects on immune-modulating therapies, such as anti VLA-4 therapy may develop progressive multifocal leukoencephalopathy (PML) which is a lytic infection of oligodendrocytes in the brain. Serum antibodies to JCV mark infection occur only in 50–60% of infected individuals, and high JCV-antibody titers seem to increase the risk of developing PML. We here investigated the role of human leukocyte antigen (HLA), instrumental in immune defense in JCV antibody response. Anti-JCV antibody status, as a surrogate for JCV infection, were compared to HLA class I and II alleles in 1621 Scandinavian persons with MS and 1064 population-based Swedish controls and associations were replicated in 718 German persons with MS. HLA-alleles were determined by SNP imputation, sequence specific (SSP) kits and a reverse PCR sequence-specific oligonucleotide (PCR-SSO) method. An initial GWAS screen displayed a strong HLA class II region signal. The HLA-DRB1*15 haplotype was strongly negatively associated to JCV sero-status in Scandinavian MS cases (OR = 0.42, p = 7×10−15) and controls (OR = 0.53, p = 2×10−5). In contrast, the DQB1*06:03 haplotype was positively associated with JCV sero-status, in Scandinavian MS cases (OR = 1.63, p = 0.006), and controls (OR = 2.69, p = 1×10−5). The German dataset confirmed these findings (OR = 0.54, p = 1×10−4 and OR = 1.58, p = 0.03 respectively for these haplotypes). HLA class II restricted immune responses, and hence CD4+ T cell immunity is pivotal for JCV infection control. Alleles within the HLA-DR1*15 haplotype are associated with a protective effect on JCV infection. Alleles within the DQB1*06:03 haplotype show an opposite association. These associations between JC virus antibody response and human leucocyte antigens supports the notion that CD4+ T cells are crucial in the immune defence to JCV and lays the ground for risk stratification for PML and development of therapy and prevention." @default.
- W2022066170 created "2016-06-24" @default.
- W2022066170 creator A5015275115 @default.
- W2022066170 creator A5027427947 @default.
- W2022066170 creator A5038097343 @default.
- W2022066170 creator A5038376395 @default.
- W2022066170 creator A5041150149 @default.
- W2022066170 creator A5053300118 @default.
- W2022066170 creator A5054389416 @default.
- W2022066170 creator A5054895816 @default.
- W2022066170 creator A5059607429 @default.
- W2022066170 creator A5067194506 @default.
- W2022066170 creator A5070458733 @default.
- W2022066170 creator A5071141746 @default.
- W2022066170 creator A5075919533 @default.
- W2022066170 creator A5078581621 @default.
- W2022066170 creator A5085407328 @default.
- W2022066170 creator A5088492600 @default.
- W2022066170 date "2014-04-24" @default.
- W2022066170 modified "2023-10-17" @default.
- W2022066170 title "JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants" @default.
- W2022066170 cites W1487904781 @default.
- W2022066170 cites W1510719635 @default.
- W2022066170 cites W1695483257 @default.
- W2022066170 cites W1969355897 @default.
- W2022066170 cites W1972343584 @default.
- W2022066170 cites W1972908383 @default.
- W2022066170 cites W1978714340 @default.
- W2022066170 cites W1983511886 @default.
- W2022066170 cites W1989733951 @default.
- W2022066170 cites W1995385281 @default.
- W2022066170 cites W2000019510 @default.
- W2022066170 cites W2002855578 @default.
- W2022066170 cites W2021550979 @default.
- W2022066170 cites W2025804561 @default.
- W2022066170 cites W2030704316 @default.
- W2022066170 cites W2032345322 @default.
- W2022066170 cites W2040547343 @default.
- W2022066170 cites W2041153875 @default.
- W2022066170 cites W2044022462 @default.
- W2022066170 cites W2069205998 @default.
- W2022066170 cites W2071808503 @default.
- W2022066170 cites W2074099214 @default.
- W2022066170 cites W2078479812 @default.
- W2022066170 cites W2083296472 @default.
- W2022066170 cites W2083343922 @default.
- W2022066170 cites W2098960309 @default.
- W2022066170 cites W2108979177 @default.
- W2022066170 cites W2110134415 @default.
- W2022066170 cites W2118132694 @default.
- W2022066170 cites W2123584222 @default.
- W2022066170 cites W2134844770 @default.
- W2022066170 cites W2135403800 @default.
- W2022066170 cites W2150676596 @default.
- W2022066170 cites W2150693209 @default.
- W2022066170 cites W2153363839 @default.
- W2022066170 cites W2153559754 @default.
- W2022066170 cites W2157752701 @default.
- W2022066170 cites W2161098179 @default.
- W2022066170 cites W2161245845 @default.
- W2022066170 cites W2161633633 @default.
- W2022066170 cites W2163521262 @default.
- W2022066170 cites W2169676611 @default.
- W2022066170 cites W2170945234 @default.
- W2022066170 cites W2314996545 @default.
- W2022066170 cites W2324555147 @default.
- W2022066170 cites W2332945656 @default.
- W2022066170 doi "https://doi.org/10.1371/journal.ppat.1004084" @default.
- W2022066170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3999271" @default.
- W2022066170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24763718" @default.
- W2022066170 hasPublicationYear "2014" @default.
- W2022066170 type Work @default.
- W2022066170 sameAs 2022066170 @default.
- W2022066170 citedByCount "47" @default.
- W2022066170 countsByYear W20220661702014 @default.
- W2022066170 countsByYear W20220661702015 @default.
- W2022066170 countsByYear W20220661702016 @default.
- W2022066170 countsByYear W20220661702017 @default.
- W2022066170 countsByYear W20220661702018 @default.
- W2022066170 countsByYear W20220661702019 @default.
- W2022066170 countsByYear W20220661702020 @default.
- W2022066170 countsByYear W20220661702021 @default.
- W2022066170 countsByYear W20220661702023 @default.
- W2022066170 crossrefType "journal-article" @default.
- W2022066170 hasAuthorship W2022066170A5015275115 @default.
- W2022066170 hasAuthorship W2022066170A5027427947 @default.
- W2022066170 hasAuthorship W2022066170A5038097343 @default.
- W2022066170 hasAuthorship W2022066170A5038376395 @default.
- W2022066170 hasAuthorship W2022066170A5041150149 @default.
- W2022066170 hasAuthorship W2022066170A5053300118 @default.
- W2022066170 hasAuthorship W2022066170A5054389416 @default.
- W2022066170 hasAuthorship W2022066170A5054895816 @default.
- W2022066170 hasAuthorship W2022066170A5059607429 @default.
- W2022066170 hasAuthorship W2022066170A5067194506 @default.
- W2022066170 hasAuthorship W2022066170A5070458733 @default.
- W2022066170 hasAuthorship W2022066170A5071141746 @default.
- W2022066170 hasAuthorship W2022066170A5075919533 @default.
- W2022066170 hasAuthorship W2022066170A5078581621 @default.